PharMerica (PMC) Reports Q3 EPS of $0.27, Beats by 7c; Guides FY08
More News related to PMC
- PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference
- PharMerica to Present at the Oppenheimer 20th Annual Healthcare Conference
- PharMerica (PMC) Tops Q3 EPS by 16c; Guides In-Line
- PharMerica Reports Results for the Third Quarter of 2009 and Nine Months Ended September 30, 2009
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to Earnings
- Highlights From CLWR's Q3 Conference Call: Funding Initiative A Go!, But Investors Worry About Long-Term Outlook
- Arden Group (ARDNA) Posts Q3 EPS of $1.48, Beats Q308 by 18c
- Macy's (M) Shows Good Progress, But Not Good Enough
- Universal Security (UUU) Share Trade Higher on Q2 Earnings Report
- American DG Energy (ADGE) Posts Q3 Loss of $0.01, In-Line with Q308
PharMerica Corporation (NYSE: PMC) reports Q3 EPS of $0.27, 7 cents better than the analyst estimate of $0.20. Revenue for the quarter was $486.2 million, versus the consensus of $482.79 million.
Sees FY08 EPS of $0.85-$0.89, versus the consensus of $0.85 and revs of $1.945-$1.965 billion, versus the consensus of $1.96 billion.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.16Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
